Showing 1021-1030 of 1782 results for "".
- An Obesity Drug Prevents Covid Deaths, Study Suggestshttps://reachmd.com/news/an-obesity-drug-prevents-covid-deaths-study-suggests/2468102/Wegovy, the popular obesity drug, may have yet another surprising benefit. In a large clinical trial, people taking the drug during the pandemic were less likely to die of Covid-19, r
- Outsmarting Chemo-Resistant Ovarian Cancerhttps://reachmd.com/news/outsmarting-chemo-resistant-ovarian-cancer/2457277/CHICAGO --- Women diagnosed with ovarian cancer may initially respond well to chemotherapy, but the majority of them will develop resistance to treatment and die from the disease.Now Northwestern Medicine scientists have disc
- ResearchPharmacological Inhibitor Protects Nerve Cells in ALS Diseasehttps://reachmd.com/news/researchpharmacological-inhibitor-protects-nerve-cells-in-als-disease/2457127/ALS is a degenerative disease of the nervous system particularly affecting and harmful to motor neurons. As the disease progresses, the nerve cells controlling voluntary muscle movement die. That leads to a progressive wasting of the muscles responsible for moving and speaking, but also
- People Who Experienced Childhood Adversity Had Poorer COVID-19 Outcomes, New Study Showshttps://reachmd.com/news/people-who-experienced-childhood-adversity-had-poorer-covid-19-outcomes-new-study-shows/2456703/Adults who faced adversity during childhood were significantly more likely to die from or be hospitalized because of COVID-19. That’s the key finding of my team’s recent study, published in
- Exploring the Shift to Oral GLP-1 Pills: Implications for Primary Carehttps://reachmd.com/news/exploring-the-shift-to-oral-glp-1-pills-implications-for-primary-care/2484634/Semaglutide's move into oral formulations from the makers of Wegovy could be a turning point for obesity management in primary care. The emergence of
- Efficacy and Safety of Evolocumab in Primary Prevention: Insights from Recent Trialshttps://reachmd.com/news/efficacy-and-safety-of-evolocumab-in-primary-prevention-insights-from-recent-trials/2484434/In a pivotal trial, evolocumab reduced the risk of a first major cardiovascular event by 25% (three‑point
- Unveiling Shared Heritability in Psychiatric Disorders: Insights from Recent Genomic Studieshttps://reachmd.com/news/unveiling-shared-heritability-in-psychiatric-disorders-insights-from-recent-genomic-studies/2484905/A large genomics meta-analysis suggests five genetic families account for most shared heritable risk across 14 psychiatric disorders, pointing to transdiagnost
- Environmental Exposures and Inflammatory Skin Disease: The Role of Hormone-Disrupting Chemicalshttps://reachmd.com/news/environmental-exposures-and-inflammatory-skin-disease-the-role-of-hormone-disrupting-chemicals/2484708/New evidence links hormone-disrupting chemicals to rising rates of hidradenitis suppurativa (HS). This matters because it points to a potentially modifiable environmental pathway in a
- EBSdart: A New Scale for Epidermolysis Bullosa Simplex Severityhttps://reachmd.com/news/ebsdart-a-new-scale-for-epidermolysis-bullosa-simplex-severity/2484289/EBSdart, a photo‑anchored five‑point severity scale for epidermolysis bullosa simplex, offers a standardized measure that could tighten clinical monitoring and i
- Enhancing Diagnosis of Adenoviral Conjunctivitis: Silver-Amplified Lateral Flow Kits in Focushttps://reachmd.com/news/enhancing-diagnosis-of-adenoviral-conjunctivitis-silver-amplified-lateral-flow-kits-in-focus/2484248/A recent multicenter prospective study in Viruses shows that silver‑amplified lateral flow kits substantially improve point‑of‑care detection of adenoviral conjunctivitis, with sensitivity 86.0